Rakaee M, Nassar AH, Tafavvoghi M, Jabar F, Bou Farhat E, Adib E, Andersen S, Busund LR, Pøhl M, Helland Å, Gusev A, Ricciuti B, Sholl LM, Donnem T, Kwiatkowski DJ (2026)
Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer
JAMA Oncol (in press)
DOI 10.1001/jamaoncol.2025.6430, PubMed 41678173

Kranjec C, Eilertsen IA, Nunes L, Moosavi SH, Berg KCG, Eknæs M, Hektoen M, Niederdorfer B, Lind GE, Skotheim RI, Sveen A, Lothe RA (2026)
Common gene mutations in 103 authenticated colorectal cancer cell lines
Oncogenesis, 15 (1), 8
DOI 10.1038/s41389-026-00599-0, PubMed 41593049

Svalheim KG, Andresen NK, Bjerre C, Gilje B, Jakobsen EH, Falk RS, Naume B, Kaasa S, Kyte JA (2026)
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer
Breast, 86, 104704 (in press)
DOI 10.1016/j.breast.2026.104704, PubMed 41581361

Rakaee M, Nassar AH, Tafavvoghi M, Jabar F, Bou Farhat E, Adib E, Andersen S, Busund LR, Pøhl M, Helland Å, Gusev A, Ricciuti B, Sholl LM, Donnem T, Kwiatkowski DJ (2026)
Ancestry-Associated Performance Variability of Open-Source AI Models for EGFR Prediction in Lung Cancer
JAMA Oncol (in press)
DOI 10.1001/jamaoncol.2025.6430, PubMed 41678173

Slørdahl KS, Puco K, Falk RS, Dyvik I, Brabrand S, Niehusmann P, Steinskog ESS, Blix ES, Flobak Å, Oppedal IA, Meltzer S, Torkildsen CF, Blakstad H, Lindemann K, Smeland S, Amundsen A, Taskén K, Helland Å, InPred Consortium (2026)
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial
Acta Oncol, 65, 90-96
DOI 10.2340/1651-226X.2026.45086, PubMed 41664938

Davidson B, Stričak LM, Holth A, Torgunrud A, Wohlschlaeger J, Tötsch M, Bassarova A (2026)
The specificity of HEG1 as mesothelioma marker depends on the differential diagnosis
Virchows Arch (in press)
DOI 10.1007/s00428-026-04438-w, PubMed 41656400